Literature DB >> 11438448

Circulating breast cancer cells are frequently apoptotic.

G Méhes1, A Witt, E Kubista, P F Ambros.   

Abstract

Automatic search for cytokeratin/mucin-1 double immunofluorescence was performed to detect and characterize circulating epithelial tumor cells in patients with advanced breast cancer. The peripheral blood samples in 8 of 19 patients (42.1%) presented with cytokeratin-positive and epithelial-type mucin-positive (CK(+)/MUC1(+)) tumor cells. Detailed microscopic analysis, however, suggested that the majority of the double immunopositive cells was apoptotic according to an "inclusion type" cytokeratin staining pattern and nuclear condensation. Furthermore, apoptosis-related DNA strand breaks could be demonstrated by applying the TdT-uridine nick end labeling assay in these cells. In 3 of 8 positive samples all of the CK(+)/MUC1(+) cells displayed apoptotic features. We conclude that apoptotic cells significantly contribute to the circulating tumor cell fraction in breast cancer patients. As the predictive value of such cells for the outcome of the disease is unclear, they should be considered separately when analyzing tumor cell dissemination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438448      PMCID: PMC1850424          DOI: 10.1016/S0002-9440(10)61667-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Authors:  I J Diel; M Kaufmann; S D Costa; R Holle; G von Minckwitz; E F Solomayer; S Kaul; G Bastert
Journal:  J Natl Cancer Inst       Date:  1996-11-20       Impact factor: 13.506

2.  Apoptosis generates stable fragments of human type I keratins.

Authors:  N O Ku; J Liao; M B Omary
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

3.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

Authors:  S Braun; K Pantel; P Müller; W Janni; F Hepp; C R Kentenich; S Gastroph; A Wischnik; T Dimpfl; G Kindermann; G Riethmüller; G Schlimok
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

4.  Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis.

Authors:  M P Leers; W Kölgen; V Björklund; T Bergman; G Tribbick; B Persson; P Björklund; F C Ramaekers; B Björklund; M Nap; H Jörnvall; B Schutte
Journal:  J Pathol       Date:  1999-04       Impact factor: 7.996

5.  Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis.

Authors:  M Rytömaa; L M Martins; J Downward
Journal:  Curr Biol       Date:  1999-09-23       Impact factor: 10.834

6.  Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.

Authors:  W A Franklin; J Glaspy; S M Pflaumer; R B Jones; L Hami; C Martinez; J R Murphy; E J Shpall
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

7.  Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.

Authors:  M Mori; K Mimori; H Ueo; K Tsuji; T Shiraishi; G F Barnard; K Sugimachi; T Akiyoshi
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

8.  Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

Authors:  K Pantel; J Izbicki; B Passlick; M Angstwurm; K Häussinger; O Thetter; G Riethmüller
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

9.  Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients.

Authors:  N O Funaki; J Tanaka; G Ohshio; H Onodera; S Maetani; M Imamura
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis.

Authors:  M MacFarlane; W Merrison; D Dinsdale; G M Cohen
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  75 in total

Review 1.  The detection of circulating breast cancer cells in blood.

Authors:  A M Gilbey; D Burnett; R E Coleman; I Holen
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

2.  Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA.

Authors:  Tae-Kyung Yoo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance.

Authors:  Mei Cao; Shang-Mian Yie; Sheng-Min Wu; Shu Chen; Be Lou; Xu He; Shang-Rong Ye; Ke Xie; Lin Rao; En Gao; Nai-Yao Ye
Journal:  Clin Exp Metastasis       Date:  2009-06-12       Impact factor: 5.150

Review 4.  CTC enumeration and characterization: moving toward personalized medicine.

Authors:  Angela Toss; Zhaomei Mu; Sandra Fernandez; Massimo Cristofanilli
Journal:  Ann Transl Med       Date:  2014-11

5.  Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.

Authors:  Xiaosai Yao; Atish D Choudhury; Yvonne J Yamanaka; Viktor A Adalsteinsson; Todd M Gierahn; Christina A Williamson; Carla R Lamb; Mary-Ellen Taplin; Mari Nakabayashi; Matthew S Chabot; Tiantian Li; Gwo-Shu M Lee; Jesse S Boehm; Philip W Kantoff; William C Hahn; K Dane Wittrup; J Christopher Love
Journal:  Integr Biol (Camb)       Date:  2014-02-13       Impact factor: 2.192

6.  Retrieval of Disseminated Tumor Cells Colonizing the Bone in Murine Breast Cancer Metastasis Models.

Authors:  Thomas Welte; Cuijuan Yu; Xiang H-F Zhang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-12       Impact factor: 2.673

7.  Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.

Authors:  Edward W Howard; Steve C L Leung; H F Yuen; Chee Wai Chua; Davy T Lee; K W Chan; Xianghong Wang; Yong Chuan Wong
Journal:  Clin Exp Metastasis       Date:  2008-03-14       Impact factor: 5.150

8.  Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis.

Authors:  Qicheng Zhao; Monica Barclay; John Hilkens; Xiuli Guo; Hannah Barrow; Jonathan M Rhodes; Lu-Gang Yu
Journal:  Mol Cancer       Date:  2010-06-18       Impact factor: 27.401

9.  Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection.

Authors:  Lili Wang; Yanyan Wang; Yajing Liu; Min Cheng; Xu Wu; Haiming Wei
Journal:  J Exp Clin Cancer Res       Date:  2009-04-28

10.  Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.

Authors:  Heidi Schwarzenbach; Klaus Pantel; Birthe Kemper; Cord Beeger; Friedrich Otterbach; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.